Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew A Cooper

Showing results (281-290 of 310) with videos related to

Pageof 31
Sort By:
Cardiovascular Research|October 26, 2018
Pharmacological inhibition of the NLRP3 inflammasome reduces blood pressure, renal damage, and dysfunction in salt-sensitive hypertensionShalini M Krishnan, Yeong H Ling, Brooke M Huuskes, et al.
ACS Infectious Diseases|April 25, 2020
Discovery of Cephalosporin-3'-Diazeniumdiolates That Show Dual Antibacterial and Antibiofilm Effects against <i>Pseudomonas aeruginosa</i> Clinical Cystic Fibrosis Isolates and Efficacy in a Murine Respiratory Infection ModelArdeshir Rineh, Odel Soren, Timothy McEwan, et al.
Immunity|August 18, 2016
Programmed Death-1 Ligand 2-Mediated Regulation of the PD-L1 to PD-1 Axis Is Essential for Establishing CD4(+) T Cell ImmunityDeshapriya S Karunarathne, Joshua M Horne-Debets, Johnny X Huang, et al.
Nature Communications|January 12, 2022
Towards a generic prototyping approach for therapeutically-relevant peptides and proteins in a cell-free translation systemYue Wu, Zhenling Cui, Yen-Hua Huang, et al.
Blood|October 15, 2016
The NLRP3 inflammasome functions as a driver of the myelodysplastic syndrome phenotypeAshley A Basiorka, Kathy L McGraw, Erika A Eksioglu, et al.
Nature Communications|July 22, 2015
Carbohydrate scaffolds as glycosyltransferase inhibitors with in vivo antibacterial activityJohannes Zuegg, Craig Muldoon, George Adamson, et al.
Science (New York, N.Y.)|June 18, 2016
T helper 1 immunity requires complement-driven NLRP3 inflammasome activity in CD4⁺ T cellsGiuseppina Arbore, Erin E West, Rosanne Spolski, et al.
ERJ Open Research|March 30, 2018
Multiple inflammasomes may regulate the interleukin-1-driven inflammation in protracted bacterial bronchitisAlice C-H Chen, Hai B Tran, Yang Xi, et al.
American Journal of Respiratory and Critical Care Medicine|March 3, 2017
Role for NLRP3 Inflammasome-mediated, IL-1β-Dependent Responses in Severe, Steroid-Resistant AsthmaRichard Y Kim, James W Pinkerton, Ama T Essilfie, et al.
Journal of Medicinal Chemistry|November 25, 2024
Novel Macrocyclic NLRP3 InhibitorsStefanie Mesch, Jonathan Shannon, David Miller, et al.
Pageof 31

Showing results (281-290 of 310) with videos related to

Sort By:
Pageof 31
Cardiovascular Research|October 26, 2018
Pharmacological inhibition of the NLRP3 inflammasome reduces blood pressure, renal damage, and dysfunction in salt-sensitive hypertensionShalini M Krishnan, Yeong H Ling, Brooke M Huuskes, et al.
ACS Infectious Diseases|April 25, 2020
Discovery of Cephalosporin-3'-Diazeniumdiolates That Show Dual Antibacterial and Antibiofilm Effects against <i>Pseudomonas aeruginosa</i> Clinical Cystic Fibrosis Isolates and Efficacy in a Murine Respiratory Infection ModelArdeshir Rineh, Odel Soren, Timothy McEwan, et al.
Immunity|August 18, 2016
Programmed Death-1 Ligand 2-Mediated Regulation of the PD-L1 to PD-1 Axis Is Essential for Establishing CD4(+) T Cell ImmunityDeshapriya S Karunarathne, Joshua M Horne-Debets, Johnny X Huang, et al.
Nature Communications|January 12, 2022
Towards a generic prototyping approach for therapeutically-relevant peptides and proteins in a cell-free translation systemYue Wu, Zhenling Cui, Yen-Hua Huang, et al.
Blood|October 15, 2016
The NLRP3 inflammasome functions as a driver of the myelodysplastic syndrome phenotypeAshley A Basiorka, Kathy L McGraw, Erika A Eksioglu, et al.
Nature Communications|July 22, 2015
Carbohydrate scaffolds as glycosyltransferase inhibitors with in vivo antibacterial activityJohannes Zuegg, Craig Muldoon, George Adamson, et al.
Science (New York, N.Y.)|June 18, 2016
T helper 1 immunity requires complement-driven NLRP3 inflammasome activity in CD4⁺ T cellsGiuseppina Arbore, Erin E West, Rosanne Spolski, et al.
ERJ Open Research|March 30, 2018
Multiple inflammasomes may regulate the interleukin-1-driven inflammation in protracted bacterial bronchitisAlice C-H Chen, Hai B Tran, Yang Xi, et al.
American Journal of Respiratory and Critical Care Medicine|March 3, 2017
Role for NLRP3 Inflammasome-mediated, IL-1β-Dependent Responses in Severe, Steroid-Resistant AsthmaRichard Y Kim, James W Pinkerton, Ama T Essilfie, et al.
Journal of Medicinal Chemistry|November 25, 2024
Novel Macrocyclic NLRP3 InhibitorsStefanie Mesch, Jonathan Shannon, David Miller, et al.
Pageof 31